Blutungsrisiko bei der Behandlung mit Antidepressiva: Klinische Schlussfolgerungen

de Abajo FJ, Montero D, Rodriguez LA, Madurga M (2006) Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol 98:304–310 Andreasen JJ, Riis A, Hjortdal VE, Jørgensen J, Sørensen HT, Johnsen SP (2006) Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery. Am J Cardiovasc Drugs 6:243–250 Halperin D, Reber B (2007) Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 9:47–59 Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC (2004) Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 164:2367–2370 Ramasubbu R (2004) Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review. J Clin Psychiatry 65:1642–1653 Schlienger RG, Fischer LM, Jick H, Meier CR (2004) Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf 27:1157–1165 Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT, et al. (2003) Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SAD-HART) Platelet Substudy. Circulation 108:939–944